Open AccessNeutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine
Author(s) -
Deepali Kumar,
Victor H Ferreira,
Victoria Hall,
Queenie Hu,
Reuben Samson,
Terrance Ku,
Matthew Ierullo,
Beata Majchrzak-Kita,
George Tomlinson,
AnneClaude Gingras,
Atul Humar
Publication year - 2022
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m21-3480
Subject(s) - neutralization , medicine , placebo , immunogenicity , virology , virus , immunology , neutralizing antibody , antibody , pathology , alternative medicine
COVID-19 is more severe in transplant recipients. Variants of concern have supplanted wild-type virus. In transplant recipients, data are limited on 2-dose or 3-dose vaccine immunogenicity against variant viruses.